Loading…
A Nucleolar Isoform of the Fbw7 Ubiquitin Ligase Regulates c-Myc and Cell Size
The human tumor suppressor Fbw7/hCdc4 functions as a phosphoepitope-specific substrate recognition component of SCF ubiquitin ligases [1] that catalyzes the ubiquitination of cyclin E [2–5], Notch [6, 7], c-Jun [8] and c-Myc [9–10]. Fbw7 loss in cancer may thus have profound effects on the pathways...
Saved in:
Published in: | Current biology 2004-10, Vol.14 (20), p.1852-1857 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The human tumor suppressor Fbw7/hCdc4 functions as a phosphoepitope-specific substrate recognition component of SCF ubiquitin ligases
[1] that catalyzes the ubiquitination of cyclin E
[2–5], Notch
[6, 7], c-Jun
[8] and c-Myc
[9–10]. Fbw7 loss in cancer may thus have profound effects on the pathways that govern cell division, differentiation, apoptosis, and cell growth. Fbw7-inactivating mutations occur in human tumor cell lines
[2–4] and primary cancers
[11–13], and Fbw7 loss in cultured cells causes genetic instability
[13]. In mice, deletion of
Fbw7 leads to embryonic lethality associated with defective Notch and cyclin E regulation
[14, 15]. The human
Fbw7 locus encodes three protein isoforms (Fbw7α, Fbw7β, and Fbw7γ)
[2–4, 11]. We find that these isoforms occupy discrete subcellular compartments and have identified
cis-acting localization signals within each isoform. Surprisingly, the Fbw7γ isoform is nucleolar, colocalizes with c-Myc when the proteasome is inhibited, and regulates nucleolar c-Myc accumulation. Moreover, we find that knockdown of Fbw7 increases cell size consistent with its ability to control c-Myc levels in the nucleolus. We suggest that interactions between c-Myc and Fbw7γ within the nucleolus regulate c-Myc's growth-promoting function and that c-Myc activation is likely to be an important oncogenic consequence of Fbw7 loss in cancers. |
---|---|
ISSN: | 0960-9822 1879-0445 |
DOI: | 10.1016/j.cub.2004.09.083 |